A 12-week clinical trial by [17] using the probiotic blend WBF-011 (containing A. muciniphila) significantly improved postprandial glucose and HbA1c in T2DM patients, likely via butyrate-induced GLP-1 release. Here, GLP1R is linked to type 2 diabetes mellitus.